tradingkey.logo

Inotiv Inc

NOTV
查看详细走势图
0.668USD
+0.022+3.33%
收盘 12/19, 16:00美东报价延迟15分钟
22.95M总市值
亏损市盈率 TTM

Inotiv Inc

0.668
+0.022+3.33%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+3.33%

5天

-12.58%

1月

-21.91%

6月

-67.41%

今年开始到现在

-83.86%

1年

-83.63%

查看详细走势图

TradingKey Inotiv Inc股票评分

单位: USD 更新时间: 2025-12-19

操作建议

Inotiv Inc当前公司基本面数据相对稳定,增长潜力很大。当前估值合理,在生物技术与医疗研究行业排名146/404位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价4.83。中期看,股价处于下降通道。近一个月,市场表现非常差,但基本面评分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Inotiv Inc评分

相关信息

行业排名
146 / 404
全市场排名
270 / 4582
所属行业
生物技术与医疗研究

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 3 位分析师
买入
评级
4.833
目标均价
+482.33%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Inotiv Inc亮点

亮点风险
Inotiv, Inc. is a contract research company engaged in providing nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to the same industries, as well as academia and government clients. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. It operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through DSA segment, it supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through RMS segment, it offers access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.
估值高估
公司最新PE估值-0.32,处于3年历史高位
机构减仓
最新机构持股8.82M股,环比减少27.89%
景顺投资公司持仓
明星投资者景顺投资公司持仓,最新持仓市值79.45K

Inotiv Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Inotiv Inc简介

Inotiv, Inc. is a contract research company engaged in providing nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to the same industries, as well as academia and government clients. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. It operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through DSA segment, it supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through RMS segment, it offers access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.
公司代码NOTV
公司Inotiv Inc
CEOLeasure (Robert W)
网址https://www.inotiv.com/

常见问题

Inotiv Inc(NOTV)的当前股价是多少?

Inotiv Inc(NOTV)的当前股价是 0.668。

Inotiv Inc的股票代码是什么?

Inotiv Inc的股票代码是NOTV。

Inotiv Inc股票的52周最高点是多少?

Inotiv Inc股票的52周最高点是5.670。

Inotiv Inc股票的52周最低点是多少?

Inotiv Inc股票的52周最低点是0.610。

Inotiv Inc的市值是多少?

Inotiv Inc的市值是22.95M。

Inotiv Inc的净利润是多少?

Inotiv Inc的净利润为-68.63M。

现在Inotiv Inc(NOTV)的股票是买入、持有还是卖出?

根据分析师评级,Inotiv Inc(NOTV)的总体评级为买入,目标价格为4.833。

Inotiv Inc(NOTV)股票的每股收益(EPS TTM)是多少

Inotiv Inc(NOTV)股票的每股收益(EPS TTM)是-2.115。
KeyAI